Close

Articles Posted in Menlo Therapeutics

Updated:

Menlo Therapeutics (“MNLO”) I.P.O. Losses

In January 2018, Menlo Therapeutics went public issuing over 8,000,000 shares of common stock at a public offering price of $17.00 raising over 125 million dollars.  NASDAQ lists Menlo’s stock under the ticker symbol “MNLO.” Jefferies LLC, Piper Jaffray & Co. and Guggenheim Securities served as the lead underwriters.  Menlo’s…

Contact Us